Pfizer RSV Vaccine May Protect High-Risk Adults Ages 18-59
Respiratory syncytial virus: viral vaccine under investigation Hail | Stock | fake images a vaccine Pfizer showed the potential to…
pfizer inc
Biotech stocks are ready to break out. They just need one more thing
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…
Pfizer RSV vaccine protects older adults for two seasons
Respiratory syncytial virus vial. Manjurul | Stock | fake images PfizerThe respiratory syncytial virus vaccine maintained protection in older adults…
New Pet Medications Look Much More Like Human Medications
If you want to understand how different the human and animal drug and vaccine industries have historically been, you don't…
Viking Therapeutics' weight loss drug shows promising trial results
CR | Stock | fake images Actions of Viking therapeutics surged more than 80% in premarket trading on Tuesday after…
Why We Would Consider Buying More Eli Lilly Stock If It Were Down
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Medicare Drug Price Negotiations: Judge Dismisses PhRMA Lawsuit
Activists protest prescription drug pricing in front of the U.S. Department of Health and Human Services (HHS) building on October…
Novo Nordisk and Eli Lilly address supply issues
In this photo illustration, injectable pens of the weight loss drug Wegovy from Novo Nordisk are shown in Oslo, Norway,…
GSK sees huge RSV vaccine sales, raises outlook
The logo of pharmaceutical company GlaxoSmithKline is seen at its facility in Stevenage, Britain, October 26, 2020. Ruvic Dice |…
Bristol Myers Squibb (BMY) Q4 2023 Earnings Report
Bristol-Myers Squibb reported quarterly earnings and revenue on Friday that beat expectations as its portfolio of new drugs posted strong…